Networks of innovation: vaccine development at Merck, Sharp & Dohme, and Mulford, 1895–1995

Key Points

• Vaccine development transformed public health over a century, highlighting innovative approaches.
• Notable advancements include the introduction of new vaccines, improving health outcomes for many.
• The analysis investigates historical records on clinical trials and innovation networks at Merck.
• Implications emphasize the need for continued collaboration in biotechnology and public health.